EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resilience in Alzheimer's disease: Impact of operationalization and methodological choices

Sophie Mutel iD, Lara Quatrocchi, Daniele Altomare, Christian Chicherio, Max Scheffler, Karl-Olof Lövblad, Kaj Blennow, Nicholas J Ashton, Henrik Zetterberg, Marc Abramowicz, Jean-Louis Blouin, Chen Wang und 5 weitere

Alzheimer's & Dementia · 2025-04 · 21 (4)

DOI: 10.1002/alz.70185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 28.04.2025. Verfasst von Sophie Mutel und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Alzheimer Disease, Resilience, Psychological, Brain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Resilience, the ability to maintain cognition or brain integrity despite Alzheimer's disease (AD) pathology, is often quantified using the residual approach. However, the variability in methodology and correction methods for this approach raises concerns about the interpretability of findings across studies. METHODS We assessed brain resilience (BR) and cognitive resilience (CR) in a memory clinic population using the residual approach. We compared non‐corrected and corrected residuals’ associations with risk factors using linear regression models, and their impact on longitudinal cognition using linear mixed‐effects models. RESULTS Corrected versus non‐corrected BR yielded distinct, often opposing, associations. For example, glial fibrillary acidic protein (GFAP) was negatively associated with non‐corrected BR (β = –0.33; p < 0.01) but positively with corrected BR (β = 0.5, p < 0.001). Only corrected CR measures yielded significant associations. Only corrected residuals predicted cognitive decline. DISCUSSION The observed discrepancies raise questions about the reliability of the residual approach in accurately capturing resilience. Highlights Corrected and non‐corrected residuals show distinct associations with risk factors. Corrected and non‐corrected residuals show different predictions of cognitive decline. These approaches may reflect general brain health rather than true resilience mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseResilience, PsychologicalBrainHumansMaleFemaleAgedNeuropsychological TestsAged, 80 and overLongitudinal StudiesRisk FactorsCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer's disease resiliencebrain resiliencecognitive declinecognitive resilienceresidual approachresidual correction methodsrisk factors

Autor:innen und Institutionen

  • Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
  • Geneva Memory Centre, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
  • Competence Centre on Ageing (CCA), Department of Business Economics, Health and Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Manno, Switzerland.
  • Center for Interdisciplinary Study of Gerontology and Vulnerability (CIGEV), University of Geneva, Carouge, Switzerland.
  • Division of Radiology, Geneva University Hospitals, Thonex, Switzerland.
  • Neurodiagnostic and Neurointerventional Division, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.

ORCID-Profile: Sophie Mutel, Federica Ribaldi

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Mutel, S., Quatrocchi, L., Altomare, D., Chicherio, C., Scheffler, M., Lövblad, K. O., Blennow, K., Ashton, N. J., Zetterberg, H., Abramowicz, M., Blouin, J. L., Wang, C., Wyss-Dominguez, C., Mendes, A. J., Garibotto, V., Frisoni, G., & Ribaldi, F. (2025). Resilience in Alzheimer's disease: Impact of operationalization and methodological choices. Alzheimer's & Dementia, 21(4). https://doi.org/10.1002/alz.70185

Vancouver

Mutel S, Quatrocchi L, Altomare D, Chicherio C, Scheffler M, Lövblad KO, et al. Resilience in Alzheimer's disease: Impact of operationalization and methodological choices. Alzheimer's & Dementia. 2025;21(4). doi:10.1002/alz.70185

BibTeX
@article{Mutel2025,
  author = {Mutel, Sophie and Quatrocchi, Lara and Altomare, Daniele and Chicherio, Christian and Scheffler, Max and Lövblad, Karl-Olof and Blennow, Kaj and Ashton, Nicholas J and Zetterberg, Henrik and Abramowicz, Marc and Blouin, Jean-Louis and Wang, Chen and Wyss-Dominguez, Carine and Mendes, Augusto J and Garibotto, Valentina and Frisoni, Giovanni and Ribaldi, Federica},
  title = {Resilience in Alzheimer's disease: Impact of operationalization and methodological choices},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {4},
  doi = {10.1002/alz.70185}
}
Kostenlos starten →